FDA Drug Application (202829) for AMLODIPINE BESYLATE AND VALSARTAN by NOVEL LABS INC

Back to FDA Applications sponsored by NOVEL LABS INC

Application Number202829
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE;160MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAMLODIPINE BESYLATE AND VALSARTAN
Active IngredientAMLODIPINE BESYLATE; VALSARTAN

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient VALSARTAN12


Back to FDA Applications sponsored by NOVEL LABS INC